
|Articles|December 10, 2015
New EU Clinical Trials Regulation: One of the Most Important Changes in the Field in the Past Decade
Author(s)DIA
Advertisement
The EU has issued Regulation 536/2014 of the European Parliament and of The Council on Clinical Trials on Medicinal Products for Human Use, groundbreaking legislation that will allow sponsors to obtain both regulatory and ethics approval through one single portal when it is implemented at the end of 2017.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



